Literature DB >> 33463254

Frugal Innovation for Point-of-Care Diagnostics Controlling Outbreaks and Epidemics.

Tobias Miesler1, Christine Wimschneider2, Alexander Brem3,4, Lorenz Meinel1,5.   

Abstract

Today epidemics of infectious diseases occur more often and spread both faster and further due to globalization and changes in our lifestyle. One way to meet these biological threats are so-called "Frugal Innovations", which focus on the development of affordable, rapid, and easy-to-use diagnostics with widespread use. In this context, point-of-care-tests (POCTs), performed at the patient's bedside, reduce extensive waiting times and unnecessary treatments and enable effective containment measures. This Perspective covers advances in POCT diagnostics on the basis of frugal innovation characteristics that will enable a faster, less expensive, and more convenient reaction to upcoming epidemics. Established POCT systems on the health care market, as well as currently evolving technological advancements in that sector are discussed. Progress in POCT technology and insights on how to most effectively use them allows the handling of more patients in a shorter time frame and consequently improves clinical outcomes at lower cost.

Entities:  

Keywords:  Emerging Markets; Epidemics; Frugal Innovation; Point-of-Care-Tests

Mesh:

Year:  2020        PMID: 33463254     DOI: 10.1021/acsbiomaterials.9b01712

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  5 in total

Review 1.  RNA-extraction-free nano-amplified colorimetric test for point-of-care clinical diagnosis of COVID-19.

Authors:  Maha Alafeef; Parikshit Moitra; Ketan Dighe; Dipanjan Pan
Journal:  Nat Protoc       Date:  2021-04-30       Impact factor: 13.491

2.  Point-of-Care for Evaluating Antimicrobial Resistance through the Adoption of Functional Materials.

Authors:  Sima Singh; Arshid Numan; Stefano Cinti
Journal:  Anal Chem       Date:  2021-11-22       Impact factor: 6.986

Review 3.  Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry.

Authors:  Jan Maci; Petra Marešová
Journal:  Risk Manag Healthc Policy       Date:  2022-01-19

4.  Frugal manufacturing in smart factories for widespread sustainable development.

Authors:  Balkrishna C Rao
Journal:  R Soc Open Sci       Date:  2021-12-01       Impact factor: 2.963

5.  Translating daily COVID-19 screening into a simple glucose test: a proof of concept study.

Authors:  Ran Liu; Yuansheng Hu; Ying He; Tian Lan; Jingjing Zhang
Journal:  Chem Sci       Date:  2021-05-25       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.